• Dual-Action Inhibitors Accelerate p38α MAPK Dephosphorylatio

  2026-05-09

  This study unveils that certain kinase inhibitors not only block p38α MAP kinase activity but also enhance its dephosphorylation by stabilizing a phosphatase-accessible conformation. These findings suggest new strategies for achieving specificity and efficacy in kinase inhibition, with direct implications for anti-inflammatory and cancer research.

• Mechanistic Advances in Mouse Genotyping: Strategic Pathways

  2026-05-08

  This article blends mechanistic insight into DNA extraction from mouse tail tissue with strategic guidance for translational researchers. It demonstrates how APExBIO's lysis buffer, as a rapid genotyping kit component, underpins robust, reproducible workflows in preclinical genetics. Integrating recent findings on tumor microenvironment signatures in colorectal cancer, we explore how high-fidelity genotyping enables the next generation of translational oncology research. Readers will gain actionable recommendations, protocol parameters, and a roadmap for leveraging genomic DNA extraction innovations in both basic and applied contexts.

• LNP-NamiRNA Dual Pathway Suppression of Pancreatic Cancer Pr

  2026-05-08

  Yu et al. (2025) demonstrate that lipid nanoparticle (LNP)-delivered mir-200c can inhibit pancreatic cancer cell proliferation and migration via dual mechanisms: transcriptional activation of PTPN6 and post-transcriptional repression of CDH17. These findings reveal a novel regulatory paradigm for nuclear activating miRNAs (NamiRNAs) and suggest new therapeutic strategies for difficult-to-treat malignancies.

• CAFs-Derived Fatty Acids Drive Oral Cancer via Lipid Rafts

  2026-05-07

  This study reveals that cancer-associated fibroblasts (CAFs) in the tumor microenvironment secrete free fatty acids (FFAs) that are taken up by oral squamous cell carcinoma (OSCC) cells to promote lipid raft formation and activate oncogenic PI3K/AKT signaling. The findings suggest that targeting the CAF–lipid raft–signaling axis could be a promising therapeutic strategy for oral cancer progression.

• Ribonuclease R (20 U/μL): Precision Tool for Circular RNA En

  2026-05-07

  Ribonuclease R (RNase R) (20 U/μL) enables selective linear RNA degradation, facilitating robust circular RNA enrichment and in-depth RNA structure analysis. APExBIO’s RNase R is validated for stability and performance in workflows requiring high specificity for linear RNA digestion. This article details evidence, protocol parameters, and critical boundaries for scientific use.

• LY2228820: Mechanistic Insights and Assay Guidance for p38 M

  2026-05-06

  Explore the advanced mechanistic basis and assay optimization strategies for LY2228820, a leading p38 MAP kinase inhibitor. Discover how conformational dynamics and dual-action inhibition shape its research applications.

• SVP3 Hetero-Galactan from S. vaninii: Hypolipidemic Action v

  2026-05-06

  This study characterizes a unique hetero-galactan (SVP3) from Sanghuangporus vaninii and demonstrates its potent hypolipidemic effects in a mouse model, mediated through modulation of the TLR4/NF-κB inflammatory pathway. The research integrates structural, metabolic, and proteomic approaches, providing mechanistic evidence for SVP3 as a promising candidate for adjunctive hyperlipidemia therapy.

• Synergistic Apoptosis: Hyperthermia and Cisplatin via Caspas

  2026-05-05

  This study elucidates how combining hyperthermia with cisplatin enhances apoptosis and pyroptosis in cancer cells, primarily through caspase-8 accumulation and activation. The research offers mechanistic insight into the interplay between ubiquitination, caspase signaling, and cell death, informing future strategies in cancer therapy.

• LY2109761: Advanced TGF-β Receptor I/II Dual Inhibitor Workf

  2026-05-05

  LY2109761 empowers researchers to dissect TGF-β/Smad signaling with high specificity, unlocking reproducible inhibition of tumor invasion, metastasis, and fibrosis. This guide translates peer-reviewed evidence and technical know-how into actionable protocols and troubleshooting strategies for superior experimental outcomes.

• Sodium Picosulfate: Mechanism, Efficacy, and Research Integr

  2026-05-04

  Sodium Picosulfate is a potent stimulant laxative for chronic and opioid-induced constipation management, functioning via inhibition of intestinal electrolyte absorption and stimulation of colonic water secretion. This article details its chemical properties, mechanistic action, and evidence-backed research applications.

• (Z)-4-Hydroxytamoxifen: A Systems-Level Tool for Breast Canc

  2026-05-04

  (Z)-4-Hydroxytamoxifen is a potent estrogen receptor modulator that enables advanced modeling of tumor relapse and heterogeneity in breast cancer research. This article explores its unique role in dissecting resistance, stemness, and therapeutic response at the systems biology level.

• Ultrasensitive Chemiluminescent Detection: Enabling New Dept

  2026-05-03

  Explore how hypersensitive chemiluminescent detection transforms immunoblotting for low-abundance proteins, integrating mechanistic insight with strategic guidance for translational researchers. This article fuses recent advances in substrate chemistry with lessons from emerging translational models, such as the TLR4/NF-κB axis in metabolic and inflammatory disease, to provide practical, evidence-driven recommendations for achieving robust, reproducible protein detection at the translational frontier.

• Multi-Omics Mapping of Melanoma Drug Resistance via ARID1A L

  2026-05-02

  This study integrates multi-omics analyses to elucidate how ARID1A loss drives resistance to BRAF/MAPK inhibitors in melanoma, uncovering dynamic signaling rewiring and immune evasion. The findings highlight key resistance nodes—PRKD1, JUN, and NCK1—that may inform future therapeutic strategies and robust experimental models.

• 5-HT3 Antagonists Inhibit Renal OCT2/MATE1 Transport: In Vit

  2026-05-01

  George et al. systematically evaluated how five 5-HT3 receptor antagonists, including tropisetron, inhibit human renal OCT2 and MATE1 transporters in vitro. The study highlights a potential mechanism for drug–drug interactions involving antiemetics and cationic drugs, relevant to both pharmacology and renal transporter research.

• Caspase-3 Fluorometric Assay Kit: Precision in Apoptosis Ass

  2026-05-01

  Unlock sensitive, quantitative apoptosis detection with the Caspase-3 Fluorometric Assay Kit, enabling robust caspase activity measurement even in complex cell death scenarios. This guide details optimized workflows, advanced use-cases, and troubleshooting strategies backed by the latest research and best practices.

16201 records 1/1081 page Next 12345 下5页 Last page